检索结果 - Klara Balint

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Activation of Notch1 signaling is required for -catenin-mediated human primary melanoma progression

    Activation of Notch1 signaling is required for -catenin-mediated human primary melanoma progression 由 Klara Balint

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results

    Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results 由 Béatris Mastelic-Gavillet, Klara Balint, Caroline Boudousquié, Philippe O. Gannon, Lana E. Kandalaft

    出版 2019
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

    A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer 由 Lana E. Kandalaft, Cheryl Lai-Lai Chiang, János L. Tanyi, Greg Motz, Klara Balint, Rosemarie Mick, George Coukos

    出版 2013
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy

    Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy 由 Andrea Facciabene, Francesco De Sanctis, Stefano Pierini, Edimara S. Reis, Klara Balint, John G. Facciponte, Jens Rueter, Masahiro Kagabu, Paola Magotti, Evripidis Lanitis, Robert A. DeAngelis, Ronald J. Buckanovich, Wenchao Song, John D. Lambris, George Coukos

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma

    A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade o... 由 Apostolos Sarivalasis, Caroline Boudousquié, Klara Balint, Brian J. Stevenson, Philippe O. Gannon, Emanuela M. Iancu, Laetitia Rossier, Silvia Martin Lluesma, Patrice Mathevet, Christine Sempoux, George Coukos, Urania Dafni, Alexandre Harari, Michal Bassani‐Sternberg, Lana E. Kandalaft

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients

    A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancre... 由 Michal Bassani‐Sternberg, Antonia Digklia, Florian Huber, Dorothea Wagner, Christine Sempoux, Brian J. Stevenson, Anne‐Christine Thierry, Justine Michaux, HuiSong Pak, Julien Racle, Caroline Boudousquié, Klara Balint, George Coukos, David Gfeller, Silvia Martin Lluesma, Alexandre Harari, Nicolas Demartines, Lana E. Kandalaft

    出版 2019
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

    Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes 由 Chelsea C. Pinnix, John Tayu Lee, Zhao‐Jun Liu, Ronan McDaid, Klara Balint, Levi J. Beverly, Patricia Brafford, Min Xiao, Benjamin Himes, Susan E. Zabierowski, Yumi Yashiro–Ohtani, Katherine L. Nathanson, Ana Bengston, Pamela M. Pollock, Ashani T. Weeraratna, Brian J. Nickoloff, Warren S. Pear, Anthony J. Capobianco, Meenhard Herlyn

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: